Kelly Ross

572 total citations
9 papers, 276 citations indexed

About

Kelly Ross is a scholar working on Oncology, Hematology and Genetics. According to data from OpenAlex, Kelly Ross has authored 9 papers receiving a total of 276 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 3 papers in Hematology and 2 papers in Genetics. Recurrent topics in Kelly Ross's work include Acute Myeloid Leukemia Research (2 papers), Neurological diseases and metabolism (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). Kelly Ross is often cited by papers focused on Acute Myeloid Leukemia Research (2 papers), Neurological diseases and metabolism (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). Kelly Ross collaborates with scholars based in United States. Kelly Ross's co-authors include Daniel K. Benjamin, Ross E. McKinney, Randall G. Fisher, Richard L. Auten, Melissa E. Murray, Tania F. Gendron, Yong‐Jie Zhang, Rosa Rademakers, Dennis W. Dickson and Nobutaka Sakae and has published in prestigious journals such as PEDIATRICS, Alzheimer s & Dementia and Viruses.

In The Last Decade

Kelly Ross

9 papers receiving 266 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kelly Ross United States 5 106 73 66 59 55 9 276
A. P. Iori Italy 8 38 0.4× 43 0.6× 23 0.3× 23 0.4× 26 0.5× 14 245
Jasodhara Chaudhuri India 8 82 0.8× 38 0.5× 27 0.4× 78 1.3× 8 0.1× 35 274
Bengt von Zur‐Mühlen Sweden 11 54 0.5× 25 0.3× 15 0.2× 33 0.6× 10 0.2× 18 288
Francesca Baiwog Australia 10 171 1.6× 42 0.6× 6 0.1× 31 0.5× 12 0.2× 11 449
Jubran Alqanatish Saudi Arabia 6 16 0.2× 31 0.4× 27 0.4× 34 0.6× 14 0.3× 22 179
S. E. Dore Italy 10 35 0.3× 21 0.3× 16 0.2× 24 0.4× 9 0.2× 30 278
David Ferreira Australia 6 21 0.2× 46 0.6× 13 0.2× 51 0.9× 11 0.2× 25 253
Ashish Goyal India 8 199 1.9× 150 2.1× 26 0.4× 24 0.4× 52 0.9× 20 329
Angela Flores United States 5 139 1.3× 105 1.4× 26 0.4× 10 0.2× 4 0.1× 7 344
Suzanne Arinsburg United States 10 21 0.2× 14 0.2× 21 0.3× 154 2.6× 56 1.0× 22 392

Countries citing papers authored by Kelly Ross

Since Specialization
Citations

This map shows the geographic impact of Kelly Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Ross more than expected).

Fields of papers citing papers by Kelly Ross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Ross. The network helps show where Kelly Ross may publish in the future.

Co-authorship network of co-authors of Kelly Ross

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Ross. A scholar is included among the top collaborators of Kelly Ross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Ross. Kelly Ross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Pusterla, Nicola, et al.. (2024). Investigation of an Outbreak of Equine Herpesvirus-1 Myeloencephalopathy in a Population of Aged Working Equids. Viruses. 16(12). 1963–1963. 3 indexed citations
2.
Petros, William P., Kelly Ross, Michael T. Craig, et al.. (2022). Association of genetic variants and survival in patients with acute myeloid leukemia in rural Appalachia. Cancer Reports. 6(3). e1746–e1746. 3 indexed citations
3.
Bianco, Christopher, Wei Fang, Michael T. Craig, et al.. (2021). Pre-existing cardiovascular disease increases risk of atrial arrhythmia and mortality in cancer patients treated with Ibrutinib. Cardio-Oncology. 7(1). 38–38. 8 indexed citations
4.
Sakae, Nobutaka, Kevin F. Bieniek, Yong‐Jie Zhang, et al.. (2018). Poly-GR dipeptide repeat polymers correlate with neurodegeneration and Clinicopathological subtypes in C9ORF72-related brain disease. Acta Neuropathologica Communications. 6(1). 63–63. 72 indexed citations
7.
Gutman, Jonathan A., Kelly Ross, Clayton A. Smith, et al.. (2016). Chronic graft versus host disease burden and late transplant complications are lower following adult double cord blood versus matched unrelated donor peripheral blood transplantation. Bone Marrow Transplantation. 51(12). 1588–1593. 37 indexed citations
8.
Ross, Kelly, Amanda Gillespie-Twardy, Mounzer Agha, et al.. (2015). Intensive Chemotherapy in Patients Aged 70 Years or Older Newly Diagnosed With Acute Myeloid Leukemia. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 22(2). 85–92. 10 indexed citations
9.
Benjamin, Daniel K., Kelly Ross, Ross E. McKinney, et al.. (2000). When to Suspect Fungal Infection in Neonates: A Clinical Comparison ofCandida albicansandCandida parapsilosisFungemia With Coagulase-Negative Staphylococcal Bacteremia. PEDIATRICS. 106(4). 712–718. 141 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026